Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

MSCV-EZH2-PGK-Puro-IRES-GFP Citations (1)

Originally described in: Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition.
Hohmann AF, Martin LJ, Minder JL, Roe JS, Shi J, Steurer S, Bader G, McConnell D, Pearson M, Gerstberger T, Gottschamel T, Thompson D, Suzuki Y, Koegl M, Vakoc CR Nat Chem Biol. 2016 Jul 4. doi: 10.1038/nchembio.2115.
PubMed Journal

Articles Citing MSCV-EZH2-PGK-Puro-IRES-GFP

Articles
EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis. Verma A, Singh A, Singh MP, Nengroo MA, Saini KK, Satrusal SR, Khan MA, Chaturvedi P, Sinha A, Meena S, Singh AK, Datta D. Nat Commun. 2022 Nov 29;13(1):7344. doi: 10.1038/s41467-022-35059-x. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.